Sheila Siqueira Andrade is pharmacist and Ph.D in Sciences, and has long experience (15 years) in research on platelet biology and function under normal and pathological conditions. She is involved in translational research at Federal University of São Paulo and postdoctoral at University of São Paulo. Two years ago she founded a start-up PlateInnove Biotechnology, for on-demand production of growth factors through platelet bioactivation. This year, PlateInnove Biotechnology launched the first prototypes of InGrowth-angiogenesis and Platelet-based growth factor biomimetic peptide, PlateSimilis.
Partner
Katia Ferreira is a hospital pharmacist and responsible for the quality control of our products.
Technical support: Fellows FAPESP Technical Training
Cristiane Siqueira Taxa Ribeiro Lúcia Helena Borges
Idea
Flirting with innovation
First name Plateform
2017
First investor:
FAPESP
Innovative Research in Small Business program
2018
Our technology focuses on development of platelet lysates using waste blood platelets from blood banks to create nutritional supplements for stem cells research.
2019
Inspired Pivot:
Platelets as Biofactories
Using Big Data Analytics/OMICS/SECRETOME/PEPTIDOMIC, 3D cell culture and in silico design of peptides
2020
Platelet-Based Growth Factor Biomimetic Peptides
2020 to future
irst prototypes / Platelet innovation to Active ingredients for cosmeceutical application
The science and innovation behind Plateinnove Biotechnology are linked to blood “mini cells”, platelets. Platelets are cells responsible for stopping bleeding; forming new vessels (a process called angiogenesis); act in tissue regeneration. In addition, platelets are considered our “Natural Growth Factors Factory”. Given this plasticity, PlateInnove uses the recipe of our “organism”, exploring our best and most special ingredient, platelets, to produce biomimetic solutions for scientific research in the area of Cell Biology.